Skip to content
Sagan

Paper

ShallowBench: Benchmarking Generative Drug Design Models on Shallow-Pocket Targets

Unreadunread

AI summary

arXiv:2606. 06717v1 Announce Type: new Abstract: While generative AI models have demonstrated remarkable success in structure-based drug design, they predominantly rely on deep binding pockets and struggle to sample effective ligands for challenging low-pocketability targets, such as the historically "undruggable" oncology targets KRAS and MYC.